home All News open_in_new Full Article
Dianthus offers up to $1B for China biotech's autoimmune 'pipeline in a product'
today 5 d. ago attach_file Politics
attach_file
Events
attach_file
Politics
attach_file
Events
attach_file
Politics
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Economics
3 w. ago
China dodges pharmaceutical tariffs: “Most Chinese biotech companies are immune to tariffs”
attach_file
Politics
attach_file
Politics
attach_file
Politics
ID: 2940477064